Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.975 +0.175 (+9.72%)
Streaming Delayed Price Updated: 12:47 PM EST, Feb 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 2,087,921
Open 1.830
Bid (Size) 1.970 (1,600)
Ask (Size) 1.980 (2,100)
Prev. Close 1.800
Today's Range 1.800 - 2.000
52wk Range 1.330 - 2.890
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
+1.3%
+1.3%
1 Month
+19.7%
+19.7%
3 Month
+27.4%
+27.4%
6 Month
+12.2%
+12.2%
1 Year
-20.4%
-20.4%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.975
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 02/24/26 12:47 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 61.34M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 61M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.